Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271903
Max Phase: Preclinical
Molecular Formula: C20H19NO3
Molecular Weight: 321.38
Associated Items:
ID: ALA5271903
Max Phase: Preclinical
Molecular Formula: C20H19NO3
Molecular Weight: 321.38
Associated Items:
Canonical SMILES: CCCCc1c(C(=O)O)c2ccccc2n1C(=O)c1ccccc1
Standard InChI: InChI=1S/C20H19NO3/c1-2-3-12-17-18(20(23)24)15-11-7-8-13-16(15)21(17)19(22)14-9-5-4-6-10-14/h4-11,13H,2-3,12H2,1H3,(H,23,24)
Standard InChI Key: NKEQTBGRPLGHBY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 321.38 | Molecular Weight (Monoisotopic): 321.1365 | AlogP: 4.37 | #Rotatable Bonds: 5 |
Polar Surface Area: 59.30 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.60 | CX Basic pKa: | CX LogP: 4.51 | CX LogD: 1.17 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.76 | Np Likeness Score: -0.36 |
1. Danilenko AV, Volov AN, Volov NA, Platonova YB, Savilov SV.. (2023) Design, synthesis and biological evaluation of novel indole-3-carboxylic acid derivatives with antihypertensive activity., 90 [PMID:37236375] [10.1016/j.bmcl.2023.129349] |
Source(1):